Dr. Lundy is now a Principal Scientist at SystImmune Inc.

At the end of February 2019, Dr. Lundy was forced to close his lab at the University of Michigan Medical School due to insufficient funding. He has since taken a position as a Principal Scientist at SystImmune, a biotech company in Redmond, Washington that specializes in cancer immunotherapy. He maintains an Adjunct Associate Professor appointment at the University of Michigan and can still be reached at sklundy@umich.edu.